The company announced interim data showing strong systemic responses in its safety and efficacy study combining Alpha DaRT treatment with ...
The interventional oncology market valued at US$ 2.53 Billion in 2023, is forecasted to grow at a robust CAGR of 9.0%, reaching US$ 2.75 Billion in 2024 and an impressive US$ 4.24 Billion by 2029. The ...
In the first randomized trial of its kind, researchers found that adding chemoradiation to adjuvant chemotherapy did not ...
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
News Medical on MSN4d
Climate change is pushing up rates of kidney disease and urological cancersClimate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...
The findings suggest that reconsideration of current clinical guidelines, which support MRI only for symptomatic brain ...
High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...
5don MSN
A new study led by researchers at Moffitt Cancer Center shows that asymptomatic brain metastasis is more common in stage 4 ...
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Basketball Hall of Famer Dwyane Wade talked for the first time yesterday about his surgery for kidney cancer in December 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback